Article Details
Retrieved on: 2024-12-25 15:53:33
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses advances in biotechnology through the development of D-amino acid mirror-image monobodies, engineered to target and inhibit MCP-1. This innovation addresses challenges in cytokine-related diseases, utilizing protein engineering for improved stability and therapeutic potential.
Article found on: evrimagaci.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here